Sinopharm vaccine plus one Pfizer booster shot offers effective Covid protection, says Abu Dhabi immunologist thenationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationalnews.com Daily Mail and Mail on Sunday newspapers.
Al Ain: The United Arab Emirates University (UAEU) is supporting the clinical trial of the novel COVID-19 vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Russia.
The vaccine is the world s first registered vaccine based on a well-studied human adenoviral vector-based platform. Sputnik V is nearing the end of the clinical testing process with 40,000 volunteers currently involved in a phase III trial in Russia. Interim results have shown the vaccine has 92 per cent efficacy after the second dose.
Phase III trials have been announced in selected partner countries including the UAE, which has already recruited more than 500 volunteers.
Russian Sputnik vaccine in UAE: Trial partnership announced
WAM/Abu Dhabi
Reuters
UAEU to be first university in the MENA region to study the vaccine and expected to publish the results of the trial.
The UAE University (UAEU) is supporting the clinical trial of the novel Covid-19 vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Russia called Sputnik V. This is the first university in the MENA region to study the vaccine and is expected to publish the results of the trial in international peer-reviewed journals.
Phase III trials have already been announced in selected partner countries including the UAE, which has already recruited more than 500 volunteers.
The United Arab Emirates University (UAEU) is supporting the clinical trial of the novel coronavirus (COVID-19) vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Russia.